Simultaneously published with its presentation at #TCT2025
The IVUS-ACS Trial shows that IVUS-guided PCI markedly improves outcomes in ACS, especially for high-risk patients defined by the new TVF-ACS Risk-Score.
A major step forward in precision interventional cardiology.
🔗 https://t.co/ikyFC8MK6W
@ehjopen@SaDeRosa78@ProfMagnusBack@mmamas1973 #EHJOpen
Breaking from #TCT2025 San Francisco 🔥
The IVUS-ACS Trial introduces the new TVF-ACS Risk-Score, that identifies ACS patients who benefit most from IVUS-guided PCI: 60% less TVF!
📖 Simultaneous publication in @ehjopen 👉 https://t.co/bolmt6uoQb
#OpenUpYourScience! @mmamas1973
Compelling news about multimorbidity in #Afib from the EHRA-PATHS consortium: published today https://t.co/Tt1ADzaEZ3
and https://t.co/F37T5Y3fBG with the accompanying Editorial https://t.co/6tAI6uE40M! #OpenUpYourScience with @ehjopen#HorizonEU@ESC_Lavinia@ProfMagnusBack
Routine screening for H. pylori infection during hospitalization 🏥 for acute #cvMI did not 🚫 significantly ↘️ bleeding events or ↗️ clinical outcomes, based on findings from the HELP-MI SWEDEHEART trial presented at #ESCCongress. Get the details: 🔗 https://t.co/rDexwHGi11
#ESCCongress – Étude HELP-MI
Chez 18 466 patients CV, dépistage systématique de H. pylori
❌ pas de bénéfice significatif sur le risque d’hémorragie digestive
👉 Signal positif chez patients anémiques
✍️@A_Trimaille & @RakzaRedwane : https://t.co/Xq26aAycxw